Yutaka Hoshikawa

1.4k total citations
18 papers, 1.2k citations indexed

About

Yutaka Hoshikawa is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Yutaka Hoshikawa has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pharmacology. Recurrent topics in Yutaka Hoshikawa's work include Ubiquitin and proteasome pathways (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Yutaka Hoshikawa is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Yutaka Hoshikawa collaborates with scholars based in Japan, India and Germany. Yutaka Hoshikawa's co-authors include Tetsuo Noda, Minoru Yoshida, Teruhiko Beppu, Kazuhiko Igarashi, Tsuyoshi Ikura, Yasutake Katoh, Sueharu Horinouchi, Ho Jeong Kwon, Satoshi Tashiro and Mitsutoshi Setou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Yutaka Hoshikawa

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yutaka Hoshikawa Japan 14 868 187 182 155 136 18 1.2k
Marta Mendes Portugal 17 546 0.6× 120 0.6× 233 1.3× 209 1.3× 143 1.1× 31 949
Masanori Fujimoto Japan 15 575 0.7× 107 0.6× 195 1.1× 126 0.8× 201 1.5× 43 867
Motonari Takashima Japan 14 409 0.5× 167 0.9× 241 1.3× 124 0.8× 158 1.2× 22 802
Troii Hall United States 14 625 0.7× 182 1.0× 207 1.1× 37 0.2× 139 1.0× 24 943
Xuecui Guo Canada 11 815 0.9× 120 0.6× 515 2.8× 70 0.5× 147 1.1× 13 1.2k
Simone W. Span Netherlands 15 1.1k 1.3× 112 0.6× 410 2.3× 53 0.3× 176 1.3× 17 1.3k
Jeong Heon Ko South Korea 20 1.2k 1.4× 589 3.1× 371 2.0× 125 0.8× 171 1.3× 41 1.6k
Vyacheslav Akimov Denmark 17 1.2k 1.4× 154 0.8× 303 1.7× 231 1.5× 170 1.3× 34 1.6k
Maxim A. X. Tollenaere Denmark 13 760 0.9× 109 0.6× 157 0.9× 97 0.6× 70 0.5× 16 965

Countries citing papers authored by Yutaka Hoshikawa

Since Specialization
Citations

This map shows the geographic impact of Yutaka Hoshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Hoshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Hoshikawa more than expected).

Fields of papers citing papers by Yutaka Hoshikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Hoshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Hoshikawa. The network helps show where Yutaka Hoshikawa may publish in the future.

Co-authorship network of co-authors of Yutaka Hoshikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Hoshikawa. A scholar is included among the top collaborators of Yutaka Hoshikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Hoshikawa. Yutaka Hoshikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Muto, Akihiko, Hiroki Shima, Yasutake Katoh, et al.. (2016). Epigenetic Regulation of the Blimp-1 Gene (Prdm1) in B Cells Involves Bach2 and Histone Deacetylase 3. Journal of Biological Chemistry. 291(12). 6316–6330. 57 indexed citations
2.
Katoh, Yasutake, Tsuyoshi Ikura, Yutaka Hoshikawa, et al.. (2011). Methionine Adenosyltransferase II Serves as a Transcriptional Corepressor of Maf Oncoprotein. Molecular Cell. 41(5). 554–566. 149 indexed citations
3.
Tanaka, Hiroshi, Yutaka Hoshikawa, Tomoko Oh‐hara, et al.. (2009). PRMT5, a Novel TRAIL Receptor-Binding Protein, Inhibits TRAIL-Induced Apoptosis via Nuclear Factor-κB Activation. Molecular Cancer Research. 7(4). 557–569. 62 indexed citations
4.
Hirono, Seiko, Hiroki Yamaue, Yutaka Hoshikawa, et al.. (2009). Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome‐wide expression profiling. Cancer Science. 101(1). 259–266. 30 indexed citations
5.
Dohi, Yoshihiro, Tsuyoshi Ikura, Yutaka Hoshikawa, et al.. (2008). Bach1 inhibits oxidative stress–induced cellular senescence by impeding p53 function on chromatin. Nature Structural & Molecular Biology. 15(12). 1246–1254. 88 indexed citations
6.
Imai, Kazuhiro, Tomoko Ichibangase, Ryoichi Saitoh, & Yutaka Hoshikawa. (2008). A proteomics study on human breast cancer cell lines by fluorogenic derivatization–liquid chromatography/tandem mass spectrometry. Biomedical Chromatography. 22(11). 1304–1314. 35 indexed citations
7.
Shimma, Shuichi, Yuki Sugiura, Takahiro Hayasaka, et al.. (2007). MALDI-based imaging mass spectrometry revealed abnormal distribution of phospholipids in colon cancer liver metastasis. Journal of Chromatography B. 855(1). 98–103. 158 indexed citations
8.
Ushijima, Masaru, Satoshi Miyata, Shinto Eguchi, et al.. (2007). Common Peak Approach Using Mass Spectrometry Data Sets for Predicting the Effects of Anticancer Drugs on Breast Cancer. Cancer Informatics. 3. 2816855308–2816855308. 4 indexed citations
9.
Ochiai, Kyoko, Yasutake Katoh, Tsuyoshi Ikura, et al.. (2006). Plasmacytic Transcription Factor Blimp-1 Is Repressed by Bach2 in B Cells. Journal of Biological Chemistry. 281(50). 38226–38234. 130 indexed citations
10.
Kumada, Kazuki, Ryoji Yao, Tokuichi Kawaguchi, et al.. (2006). The selective continued linkage of centromeres from mitosis to interphase in the absence of mammalian separase. The Journal of Cell Biology. 172(6). 835–846. 64 indexed citations
11.
Tsukiyama–Kohara, Kyoko, Shigenobu Toné, Isao Maruyama, et al.. (2004). Activation of the CKI-CDK-Rb-E2F Pathway in Full Genome Hepatitis C Virus-expressing Cells. Journal of Biological Chemistry. 279(15). 14531–14541. 52 indexed citations
12.
Maass, Nicolaì, Yukie Takimoto, Katsuhiko Sato, et al.. (2003). Expression and regulation of tumor suppressor gene maspin in human bladder cancer. Cancer Letters. 203(2). 209–215. 38 indexed citations
14.
Hoshikawa, Yutaka, et al.. (1998). Highly Controlled Heterologous Gene Expression through Combined Utilization of the Tetracycline-Repressible Transactivator and thelacRepressor. Analytical Biochemistry. 261(2). 211–218. 9 indexed citations
15.
Hoshikawa, Yutaka, et al.. (1998). Control of retinoblastoma protein-independent hematopoietic cell cycle by the pRB-related p130. Proceedings of the National Academy of Sciences. 95(15). 8574–8579. 33 indexed citations
16.
Hoshikawa, Yutaka, Ho Jeong Kwon, Minoru Yoshida, Sueharu Horinouchi, & Teruhiko Beppu. (1994). Trichostatin A Induces Morphological Changes and Gelsolin Expression by Inhibiting Histone Deacetylase in Human Carcinoma Cell Lines. Experimental Cell Research. 214(1). 189–197. 169 indexed citations
17.
Hoshikawa, Yutaka, et al.. (1991). Expression of Differentiation-related Markers in Teratocarcinoma Cells via Histone Hyperacetylation by Trichostatin A.. Agricultural and Biological Chemistry. 55(6). 1491–1495. 8 indexed citations
18.
Yoshida, Minoru, Yutaka Hoshikawa, Koshi Koseki, Kenji Mori, & Teruhiko Beppu. (1990). Structural specificity for biological activity of trichostatin a, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in friend leukemia cells.. The Journal of Antibiotics. 43(9). 1101–1106. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026